Most Popular

1
Contentious grain bill put directly to plenary meeting for vote
2
Yoon's approval rating plunges to all-time low
3
Will tug-of-war between doctors, government end soon?
4
Climate impacts set to cut 2050 global GDP by nearly a fifth
5
Trilateral talks acknowledge ‘serious’ slumps of won, yen

6
[Graphic News] More Koreans say they plan long-distance trips this year
7
[KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs
8
North Korea removes streetlights along cross-border roads with South
9
Russia's denial of entry of S. Korean national unrelated to bilateral ties: Seoul official
10
Farming households dip below 1m for first time in 2023

NewsletterSubscribe

Start your day with a roundup of key stories from The Korea Herald with news and comment on all that’s happening in Korea.

Ahngook Pharma’s cough syrup to be sold in C. America

By 황유미

Published : Oct. 12, 2016 - 13:52

- Link copied

[THE INVESTOR] Ahngook Pharmaceutical announced on Oct. 12 that it has signed an agreement with multinational pharmaceutical company Menarini for sales rights of its cough syrup Synatura in seven Central American countries.

The Italy-based company will have sales and marketing rights of the cough and mucus reducer in Guatemala, Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Belize. The contract amount remains undisclosed.

Synatura Syrup was introduced in 2011 by the South Korean firm.

By Hwang You-mee (glamazon@heraldcorp.com)

Ahngook Pharma’s cough syrup to be sold in C. America

More from Headlines